The binding of ryanodine to a high affinity site on the sarcoplasmic reticulum Ca2+-release channel results in a dramatic alteration in both gating and ion handling; the channel enters a high open probability, reduced-conductance state. Once bound, ryanodine does not dissociate from its site within the time frame of a single channel experiment. In this report, we describe the interactions of a synthetic ryanoid, 21-amino-9α-hydroxy-ryanodine, with the high affinity ryanodine binding site on the sheep cardiac sarcoplasmic reticulum Ca2+-release channel. The interaction of 21-amino-9α-hydroxy-ryanodine with the channel induces the occurrence of a characteristic high open probability, reduced-conductance state; however, in contrast to ryanodine, the interaction of this ryanoid with the channel is reversible under steady state conditions, with dwell times in the modified state lasting seconds. By monitoring the reversible interaction of this ryanoid with single channels under voltage clamp conditions, we have established a number of novel features of the ryanoid binding reaction. (a) Modification of channel function occurs when a single molecule of ryanoid binds to the channel protein. (b) The ryanoid has access to its binding site only from the cytosolic side of the channel and the site is available only when the channel is open. (c) The interaction of 21-amino-9α-hydroxy-ryanodine with its binding site is influenced strongly by transmembrane voltage. We suggest that this voltage dependence is derived from a voltage-driven conformational alteration of the channel protein that changes the affinity of the binding site, rather than the translocation of the ryanoid into the voltage drop across the channel.
Skip Nav Destination
Article navigation
Article|
July 01 1998
Interactions of a Reversible Ryanoid (21-Amino-9α-Hydroxy-Ryanodine) with Single Sheep Cardiac Ryanodine Receptor Channels
Bhavna Tanna,
Bhavna Tanna
From *Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, London SW3 6LY, United Kingdom; ‡Department of Biochemistry, and ‖Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557; and §Department of Chemistry, University of Sherbrooke, Sherbrooke, Quebec JK1 2R1, Canada
Search for other works by this author on:
William Welch,
William Welch
From *Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, London SW3 6LY, United Kingdom; ‡Department of Biochemistry, and ‖Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557; and §Department of Chemistry, University of Sherbrooke, Sherbrooke, Quebec JK1 2R1, Canada
Search for other works by this author on:
Luc Ruest,
Luc Ruest
From *Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, London SW3 6LY, United Kingdom; ‡Department of Biochemistry, and ‖Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557; and §Department of Chemistry, University of Sherbrooke, Sherbrooke, Quebec JK1 2R1, Canada
Search for other works by this author on:
John L. Sutko,
John L. Sutko
From *Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, London SW3 6LY, United Kingdom; ‡Department of Biochemistry, and ‖Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557; and §Department of Chemistry, University of Sherbrooke, Sherbrooke, Quebec JK1 2R1, Canada
Search for other works by this author on:
Alan J. Williams
Alan J. Williams
From *Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, London SW3 6LY, United Kingdom; ‡Department of Biochemistry, and ‖Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557; and §Department of Chemistry, University of Sherbrooke, Sherbrooke, Quebec JK1 2R1, Canada
Search for other works by this author on:
Bhavna Tanna
,
William Welch
,
Luc Ruest
,
John L. Sutko
,
Alan J. Williams
From *Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, London SW3 6LY, United Kingdom; ‡Department of Biochemistry, and ‖Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557; and §Department of Chemistry, University of Sherbrooke, Sherbrooke, Quebec JK1 2R1, Canada
Address correspondence to Prof. Alan J. Williams, Cardiac Medicine, National Heart & Lung Institute, Imperial College of Science, Technology & Medicine, Dovehouse St., London SW3 6LY, UK. Fax: +44 (0)171 823 3392; E-mail: [email protected]
Received:
March 18 1998
Accepted:
April 29 1998
Online ISSN: 1540-7748
Print ISSN: 0022-1295
1998
J Gen Physiol (1998) 112 (1): 55–69.
Article history
Received:
March 18 1998
Accepted:
April 29 1998
Citation
Bhavna Tanna, William Welch, Luc Ruest, John L. Sutko, Alan J. Williams; Interactions of a Reversible Ryanoid (21-Amino-9α-Hydroxy-Ryanodine) with Single Sheep Cardiac Ryanodine Receptor Channels . J Gen Physiol 1 July 1998; 112 (1): 55–69. doi: https://doi.org/10.1085/jgp.112.1.55
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
An Anionic Ryanoid, 10-O-succinoylryanodol, Provides Insights into the Mechanisms Governing the Interaction of Ryanoids and the Subsequent Altered Function of Ryanodine-receptor Channels
J Gen Physiol (May,2003)
Email alerts
Advertisement